Figure 2.
Occurrence of adverse effects by initial dose and titration interval (safety analysis set).aTwo patients who took an initial perampanel dose of 4 mg were excluded from the analysis.bPatients who had a titration interval ≥eight weeks were excluded from the analysis as the distribution of the titration interval was wide (8-102 weeks). CI: confidence interval; OR: odds ratio.